Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ASP5354 in Healthy Adult Japanese Male Participants
Clinical trial NCT04878471 · COMPLETED
Trial details
- NCT number
- NCT04878471
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-02
- Primary completion
- 2021-07-22
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.